financetom
Business
financetom
/
Business
/
Evolv Technologies Gets US Patent for Technology Used in Evolv Express
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Evolv Technologies Gets US Patent for Technology Used in Evolv Express
Aug 13, 2024 8:14 AM

10:50 AM EDT, 08/13/2024 (MT Newswires) -- Evolv Technologies ( EVLV ) said Tuesday it was awarded a patent from the US Patent and Trademark Office for the technology used in its flagship product, Evolv Express.

The Evolv Express weapons detection system is deployed in stadiums, theme parks, schools, hospitals and other public spaces around the world, the company said.

Shares of Evolv Technologies ( EVLV ) were up about 5% in recent trading.

Price: 3.01, Change: +0.15, Percent Change: +5.07

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Peyto Exploration Develops Record 76.2 Million MMboe Reserves in 2024
Peyto Exploration Develops Record 76.2 Million MMboe Reserves in 2024
Feb 21, 2025
07:25 AM EST, 02/21/2025 (MT Newswires) -- Peyto Exploration & Development ( PEYUF ) overnight Thursday said its 2024 drilling program developed a record 76.2 million barrels of oil equivalent (MMboe) of new Proved Developed Producing (PDP) reserves. The company estimates a total base decline rate of 27% this year, from December's monthly average production of 136 Mboe/d. Its capital...
Dream Office REIT Halves Q4 Net Loss, But Also Reports Lower FFO
Dream Office REIT Halves Q4 Net Loss, But Also Reports Lower FFO
Feb 21, 2025
07:24 AM EST, 02/21/2025 (MT Newswires) -- DREAM OFFICE REIT (D-UN.TO) overnight Thursday said it had more than halved its net loss in the fourth quarter, but also reported lower funds from operations as it cited significant macro-economic uncertainties and continuing challenges in the Canadian office real estate sector. For the three months ended December 31, 2024, the Trust generated...
Brady's Fiscal Q2 Adjusted Earnings, Revenue Rise; Updates Annual Guidance
Brady's Fiscal Q2 Adjusted Earnings, Revenue Rise; Updates Annual Guidance
Feb 21, 2025
07:20 AM EST, 02/21/2025 (MT Newswires) -- Brady (BRC) reported fiscal Q2 adjusted earnings Friday of $1, up from $0.93 a year earlier. Two analysts polled by FactSet expected $1.03. Revenue for the quarter ended Jan. 31 was $356.7 million compared with $322.6 million a year earlier. Two analysts surveyed by FactSet expected $359.2 million. The company raised the low...
Protagonist Therapeutics' Q4 Earnings, License and Collaboration Revenue Rise
Protagonist Therapeutics' Q4 Earnings, License and Collaboration Revenue Rise
Feb 21, 2025
07:24 AM EST, 02/21/2025 (MT Newswires) -- Protagonist Therapeutics ( PTGX ) reported Q4 earnings Friday of $1.98 per diluted share, up from $0.44 a year earlier. License and collaboration revenue for the quarter ended Dec. 31 was $170.6 million, compared with $60 million a year earlier. The company said it expects its cash, cash equivalents and marketable securities of...
Copyright 2023-2026 - www.financetom.com All Rights Reserved